Investor insights
Sectors invested in
Life Science1
Biotechnology1
Pharmaceutical1
Funding rounds participated in
$194M sweet spot round size
Most of their 1 investments are in rounds between $194M and $194M
Basic info
Industry
pharmaceutical manufacturing
Sectors
Biotechnology
Nephrology clinical development
RWE-Late Phase Clinical Research
Medical Device and Diagnostics
Infectious Disease clinical development
Cell and gene therapy clinical development
Imaging & ECG Core Labs
Phase II-III Clinical Research
Regulatory Affairs
Medical Writing
Clinical Monitoring
Neuroscience clinical development
Oncology clinical development
Clinical Trial Management
Cardiovascular clinical development
Biostatistics and Data Sciences
Drug Safety and Pharmacovigilance
Rare disease clinical development
Central Laboratories
Pharmaceutical
Bioanalytical Laboratories
Metabolic and endocrine clinical development
Quality Assurance
Early Phase Clinical Research
Date founded
1992
Investments made
N
NewAmsterdam Pharma raised $194M on January 14, 2021
Investors: Forbion, GL Capital Group, Morningside Venture Capital 晨兴资本, JVC Investment Partners, Presight Capital, LSP (Life Sciences Partners) and Medpace